Produktinformation
- Sch 619734
- 1,7-Diazaspiro[4.5]decan-2-one, 8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-, hydrochloride (1:1), (5S,8S)-
- 1,7-Diazaspiro[4.5]decan-2-one, 8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-, monohydrochloride, (5S,8S)-
Rolapitant hydrochloride is a substance that belongs to the group of neurokinin-1 receptor antagonists. It has an inhibitory effect on the release of substance P, which is a neurotransmitter in the central nervous system. Rolapitant hydrochloride is used in the prevention and treatment of nausea and vomiting caused by cancer therapy or during pregnancy. This drug also reduces the incidence of post-operative nausea and vomiting due to surgery. Rolapitant hydrochloride is used to prevent nausea and vomiting in patients who are receiving high-dose chemotherapy for cancer treatment. Rolapitant hydrochloride is used together with other antiemetic drugs such as 5HT3 receptor antagonists, corticosteroids, dopamine receptor agonists, and benzodiazepines. It can be used in combination with other antiemetics when taking into account different properties (e.g., chemotherapeutic agents) as well as side effects (e.g., antidepressants).
Chemische Eigenschaften
Technische Anfrage zu: 3D-IJB10279 Rolapitant hydrochloride
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.
